Back to CVE records
High 8.4Published Sep 29, 2026

CVE-2026-102709Improper validation of non-secure (NS) pointers in multiple TrustZone-M non-secure callable (NSC) entry functions allows an attacker executing in the non-secure world to supply pointers to secure mem…

Updated under an hour ago ()

Does this affect you?

It affects Eclipse Foundation ThreadX. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.10%, higher than 1% of scored CVEs.

Improper validation of non-secure (NS) pointers in multiple TrustZone-M non-secure callable (NSC) entry functions allows an attacker executing in the non-secure world to supply pointers to secure memory. The secure firmware subsequently dereferences these attacker-controlled pointers without verifying that they reference non-secure memory, resulting in unintended disclosure of secure memory contents. This violates the isolation guarantees provided by Arm TrustZone-M and can be leveraged as a memory disclosure or corruption primitive that may enable recovery of sensitive cryptographic material.

CVSS
8.4 HIGH (v4.0, CNA)CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N
Weakness (CWE)
CWE-200, CWE-501, CWE-822
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.10% (percentile 1)
Assigned by
eclipse
NVD analysis
Awaiting Analysis
Record last updated
Sep 30, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Eclipse Foundation ThreadX
eclipse_foundation:threadx (from the name)
through 6.5.1.202602
CNA record

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.